Similar Items: An analysis of the upstream supply chain for second-line drugs for multidrug-resistant tuberculosis
- Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
- Strengthening the public downstream SLD supply chain for MDR-TB : lessons learnt from a Western Cape case study
- Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
- Evaluation of a radiometrically-determined regrowth model for the study of anti-tuberculosis drugs
- The influence of biomimetic nanoparticles on macrophage phenotype and their anti-mycobacterial efficacy on macrophages.
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
Author: Bam, Louzanne
- Development of a pharmaceutical product categorization framework taxonomy for the South African public healthcare pharmaceutical supply chain—VAN enabled
- An analysis of the upstream supply chain for second-line drugs for multidrug-resistant tuberculosis
- A framework to support the decision-making process for modelling of communicable diseases
- Selecting incentive interventions to encourage pharmaceutical research and development for neglected diseases: A decision-support framework
- An investigation into the prospects of existing technologies to address the challenges faced in pharmacovigilance systems
- Process flexibility in a vaccine manufacturing system under high demand uncertainty